= 17.80) were statistically significant. For the least desirable heath state (NV), TIME*METHOD interaction was also significant indicating the two factors were not independent of each other, F(5,65) = 7.51. These results showed individuals rated the same health state as less desirable (lower rating) for longer time horizons and the preference elicitation method used made a difference. Furthermore, not only were health states not "timeless", but preference reversal also occurred resulting in fates perceived as worse than death. CONCLUSIONS: For the majority of respondents the utility independence assumption with respect to time for SG and VAS methods did not hold. Similar to Bala et al. (1999) and Franic et al. (2003) the results of this study indicated preference weights as measured by SG and VAS techniques were not "timeless". Regardless of the preference measure used: both SG and VAS yield higher scores for shorter time horizons. OBJECTIVES: The primary objective was to evaluate the performance of the Georgia Medicaid program for breast cancer screening by comparing the GA Medicaid breast cancer-screening rate to the national benchmarks. The second objective was to identify patient and provider characteristics associated with the mammography use. METHODS: The study was a retrospective cohort study. The Health plan Employer Data and Information Set (HEDIS) criteria were used to measure the breast cancer screening rate for women aged 52 to 69. The 1999-2000 GA Medicaid administrative claim data, which included the eligibility files patient link to the outpatient claims, were used. The measurement year was 2000 and the 1999-2000 outpatient claims were searched for mammography claims (ICD9 = V76.11 V76.12 CPT = 76090-76092). This rate was compared with the National Committee for Quality Assurance (NCQA) breast cancer-screening rates. Univariate and logistic analyses were used to identify patient (physician visit level) and provider (physician specialty and geographic location) characteristics associated with breast cancer-screening rate. RESULTS: A total of 35,775 women aged 52-69 with two years continuous GA Medicaid eligibility were identified. Nearly half (45.7%) of the subjects in the cohort were African-American. Overall, 10,391 (29.1%) had at least one mammography during the study period. This rate is much lower than the national Medicaid median (55.6%) and the national commercial median (74.8%) rates. Women aged 65 years or older had a lower breast cancer-screening rate as compared with women under 65 (22.2% compared with 31.5%). African-American women had mammography much less often than caucasian women (18.1% compared with 53.4%). The results of the logistic models predicting mammography use for caucasian and African-American women will be reported. CON-CLUSIONS: The GA Medicaid program breast cancer screening rates were much lower than the national rates, particularly for black women. Strategies to increase mammography use for indigent women residing in GA should be sought. Guideline, and Decision Making. The literature was limited to the English language and human subjects. Articles excluded were biological or pathological studies, clinical trials or reviews mainly answering efficacy-related questions, letters, comments and editorials. The abstracts were reviewed and classified by study designs, study endpoints and study impact levels ( 1) adds to the knowledge base only; 2) affects practice polices; 3) influences the delivery of care; 4) leads to changes in health outcomes, as proposed by the Agency for Health care Research and Quality)). Full-text articles were retrieved as needed for classification. RESULTS: A total of 3255 articles were retrieved by the search, and 525 met the inclusion criteria for the analysis. Most were retrospective cohort studies (216, 41.1%). The most common endpoints were survival (371, 70.6%), followed by quality of life (102, 19.4%), economic cost (81, 15.4%), and satisfaction (17, 3.2%). A total of 481 articles (91.6%) were in level 1, 26 (5%) in level 2, 16 (3%) in level 3, and 2 (0.4%) in level 4. CONCLUSIONS: Most colorectal cancer outcomes studies published in the last five years were focused on survival and represented impact level 1 research. Satisfaction was almost ignored and hardly investigated. Outcomes research answering more than survival questions and representing higher impact levels is warranted. OBJECTIVES: In research on the effectiveness of chemotherapy, a key measure of treatment delivery is average relative dose intensity (ARDI), which summarizes delivered dosage per unit of time, relative to an accepted standard. In clinical trials, where dosages and timing are strictly controlled, the calculation and use of ARDI are well-understood. In actual practice, however, naturally-occurring events complicate the computation and interpretation of this statistic: dosage levels can be reduced, treatment cycles can be delayed or eliminated entirely, and the prescribed regimen can differ materially from the published standard. In recent naturalistic research studies and clinical performance improvement programs, various alternative methods of calculating ARDI have been presented, and have been given
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PCN27 THE BREAST CANCER SCREENING RATES OF GEORGIA MEDICAID RECIPIENTS
Chen H, Kotzan JA, Martin BC 1 The University of Georgia, Athens, GA, USA OBJECTIVES: The primary objective was to evaluate the performance of the Georgia Medicaid program for breast cancer screening by comparing the GA Medicaid breast cancer-screening rate to the national benchmarks. The second objective was to identify patient and provider characteristics associated with the mammography use. METHODS: The study was a retrospective cohort study. The Health plan Employer Data and Information Set (HEDIS) criteria were used to measure the breast cancer screening rate for women aged 52 to 69. The 1999-2000 GA Medicaid administrative claim data, which included the eligibility files patient link to the outpatient claims, were used. The measurement year was 2000 and the 1999-2000 outpatient claims were searched for mammography claims (ICD9 = V76.11 V76.12 CPT = 76090-76092). This rate was compared with the National Committee for Quality Assurance (NCQA) breast cancer-screening rates. Univariate and logistic analyses were used to identify patient (physician visit level) and provider (physician specialty and geographic location) characteristics associated with breast cancer-screening rate. RESULTS: A total of 35,775 women aged 52-69 with two years continuous GA Medicaid eligibility were identified. Nearly half (45.7%) of the subjects in the cohort were African-American. Overall, 10,391 (29.1%) had at least one mammography during the study period. This rate is much lower than the national Medicaid median (55.6%) and the national commercial median (74.8%) rates. Women aged 65 years or older had a lower breast cancer-screening rate as compared with women under 65 (22.2% compared with 31.5%). African-American women had mammography much less often than caucasian women (18.1% compared with 53.4%). The results of the logistic models predicting mammography use for caucasian and African-American women will be reported. CON-CLUSIONS: The GA Medicaid program breast cancer screening rates were much lower than the national rates, particularly for black women. Strategies to increase mammography use for indigent women residing in GA should be sought.
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PCN28 GAPS IN COLORECTAL CANCER OUTCOMES RESEARCH
Ye X 1 , Schommer JC 1 , Castellanos JW 1 , Sanchez LD 1 , Wagner S 2 1 University of Minnesota, Minneapolis, MN, USA; 2 Pfizer Corporation, New York, NY, USA OBJECTIVES: The importance of cancer outcomes research has been well recognized. The purpose of this study was to examine the current status of, and identify gaps in, colorectal cancer outcomes research. METHODS: Colorectal cancer outcomes research articles published from 1999 to 2003 were retrieved using a Medline search with keywords of "colorectal neoplasms or colorectal cancer" and the following Medical Subject Heading the English language and human subjects. Articles excluded were biological or pathological studies, clinical trials or reviews mainly answering efficacy-related questions, letters, comments and editorials. The abstracts were reviewed and classified by study designs, study endpoints and study impact levels ( 1) adds to the knowledge base only; 2) affects practice polices; 3) influences the delivery of care; 4) leads to changes in health outcomes, as proposed by the Agency for Health care Research and Quality)). Full-text articles were retrieved as needed for classification. RESULTS: A total of 3255 articles were retrieved by the search, and 525 met the inclusion criteria for the analysis. Most were retrospective cohort studies (216, 41.1%). The most common endpoints were survival (371, 70.6%), followed by quality of life (102, 19.4%), economic cost (81, 15.4%), and satisfaction (17, 3.2%). A total of 481 articles (91.6%) were in level 1, 26 (5%) in level 2, 16 (3%) in level 3, and 2 (0.4%) in level 4. CONCLUSIONS: Most colorectal cancer outcomes studies published in the last five years were focused on survival and represented impact level 1 research. Satisfaction was almost ignored and hardly investigated. Outcomes research answering more than survival questions and representing higher impact levels is warranted.
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MEASURING CHEMOTHERAPY EFFECTIVENESS IN NATURALISTIC SETTINGS: THE THREE FACES OF RELATIVE DOSE INTENSITY
Kilgore KM, Zdanis MR Cetus Group, LLC, Timonium, MD, USA OBJECTIVES: In research on the effectiveness of chemotherapy, a key measure of treatment delivery is average relative dose intensity (ARDI), which summarizes delivered dosage per unit of time, relative to an accepted standard. In clinical trials, where dosages and timing are strictly controlled, the calculation and use of ARDI are well-understood. In actual practice, however, naturally-occurring events complicate the computation and interpretation of this statistic: dosage levels can be reduced, treatment cycles can be delayed or eliminated entirely, and the prescribed regimen can differ materially from the published standard. In recent naturalistic research studies and clinical performance improvement programs, various alternative methods of calculating ARDI have been presented, and have been given
